Multiple sclerosis: current knowledge and future outlook
- PMID: 25095894
- DOI: 10.1159/000360528
Multiple sclerosis: current knowledge and future outlook
Abstract
Background: Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system characterized by demyelination and axonal loss. The etiology of MS is unknown; however, environmental and genetic factors play a key role in the development of MS. Diagnostic criteria have been adapted to facilitate earlier diagnosis with increased sensitivity and specificity. Our understanding of the pathophysiology of MS has deepened considerably in recent years, resulting in different therapies to modify the disease course. Furthermore, several drugs have lately shown efficacy in phase III studies and their approval is expected in the near future. As treatment options expand, a future challenge will be to find the optimal treatment for the individual patient.
Summary: This mini-review gives an overview of the current knowledge of MS with emphasis on the latest diagnostic criteria and both current and upcoming treatment options. Key Messages: Treatment of MS changes rapidly as the knowledge and therapeutic options in MS expand. Clinical Impact: Diagnosis of MS is based on McDonald criteria. MS therapy can be divided into relapse, disease-modifying and symptomatic treatment. Relapses are commonly treated with intravenous methylprednisolone. First-line therapy consists of either interferon-β, glatiramer acetate or teriflunomide. In general, agents used as escalation therapies (natalizumab, fingolimod and mitoxantrone) are more potent than the agents used for first-line therapy; however, these have potentially serious side effects and should be used with care.
© 2014 S. Karger AG, Basel.
Similar articles
-
Established and novel disease-modifying treatments in multiple sclerosis.J Intern Med. 2014 Apr;275(4):350-63. doi: 10.1111/joim.12203. Epub 2014 Mar 11. J Intern Med. 2014. PMID: 24444048 Review.
-
Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.Mayo Clin Proc. 2014 Feb;89(2):225-40. doi: 10.1016/j.mayocp.2013.11.002. Mayo Clin Proc. 2014. PMID: 24485135 Review.
-
Multiple sclerosis research: diagnostics, disease-modifying treatments, and emerging therapies.J Neurosci Nurs. 2013 Dec;45(6 Suppl 1):S14-23. doi: 10.1097/JNN.0000000000000020. J Neurosci Nurs. 2013. PMID: 24217187 Review.
-
Update on therapeutic options for multiple sclerosis.Neurol Clin. 2013 Aug;31(3):827-45. doi: 10.1016/j.ncl.2013.03.010. Epub 2013 May 17. Neurol Clin. 2013. PMID: 23896508 Review.
-
Induction and escalation therapies in multiple sclerosis.Antiinflamm Antiallergy Agents Med Chem. 2015;14(1):26-34. doi: 10.2174/1871523014666150504122220. Antiinflamm Antiallergy Agents Med Chem. 2015. PMID: 25938688 Review.
Cited by
-
Classification of upper limb spasticity patterns in patients with multiple sclerosis: a pilot observational study.J Rehabil Med. 2024 Aug 25;56:jrm40548. doi: 10.2340/jrm.v56.40548. J Rehabil Med. 2024. PMID: 39185546 Free PMC article.
-
Mood Associated With Health- and Social Care-Related Quality of Life in Patients With Advanced Multiple Sclerosis.Int J MS Care. 2024 Aug 1;26(Q3):199-206. doi: 10.7224/1537-2073.2023-060. eCollection 2024 May. Int J MS Care. 2024. PMID: 39091383 Free PMC article.
-
The impact of HLA-DRB1 alleles in a Hellenic, Pediatric-Onset Multiple Sclerosis cohort: Implications on clinical and neuroimaging profile.Neurol Sci. 2024 May 31. doi: 10.1007/s10072-024-07619-0. Online ahead of print. Neurol Sci. 2024. PMID: 38819529
-
Influence of STAT4 Genetic Variants and Serum Levels on Multiple Sclerosis Occurrence in the Lithuanian Population.J Clin Med. 2024 Apr 19;13(8):2385. doi: 10.3390/jcm13082385. J Clin Med. 2024. PMID: 38673659 Free PMC article.
-
The neuroprotective effect of human primary astrocytes in multiple sclerosis: In vitro model.PLoS One. 2024 Apr 2;19(4):e0300203. doi: 10.1371/journal.pone.0300203. eCollection 2024. PLoS One. 2024. PMID: 38564643 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials